Indivior Pharmaceuticals Inc
Price Action
Technical Summary
EMERGING TRENDIndivior Pharmaceuticals Inc is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 82), indicating clear outperformance against the broad market. Earnings growth of 82% provides fundamental context to the price action. However, with RSI at 78, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $34.25 | +18.55% | ABOVE |
| 50 SMA | $32.37 | +25.46% | ABOVE |
| 100 SMA | $33.55 | +21.03% | ABOVE |
| 150 SMA | $32.05 | +26.70% | ABOVE |
| 200 SMA | $29.65 | +36.95% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is INDV in an uptrend right now?
INDV has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is INDV overbought or oversold?
INDV's RSI (14) is 78. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is INDV outperforming the market?
INDV has a Relative Strength (RS) Rating of 82 out of 99. Yes, INDV is a market leader, outperforming 82% of all stocks over the past 12 months.
Where is INDV in its 52-week range?
INDV is trading at $40.61, which is 100% of its 52-week high ($40.81) and 99% above its 52-week low ($10.63).
How volatile is INDV?
INDV has a Beta of 0.68 and 52-week volatility of 41%. It's less volatile than the S&P 500 - generally more stable.